Table 1.
Name | structure | IC50a | other data | REF |
---|---|---|---|---|
BRD6989 | 500nM in vitro kinase w/CDK8-CCNC |
selective for CDK8 vs. CDK19 | 49 | |
CCT251545 | 5nM in vitro kinase w/ CDK8-CCNC |
Kd = 3.8nM (CDK8-CCNC) IC50 = 65nM (luciferase reporter) PDB: 5BNJ |
122 | |
CCT251921 | 2.3nM Lanthascreen or reporter displacement (CDK8-CCNC) |
IC50 ~ 20 nM (luciferase reporter) PDB: 5HBJ |
153 | |
compound 2b | 1.8nM Lanthascreen or reporter displacement (CDK8-CCNC) |
GI50 = 2nM+ (many lines tested) IC50 ~ 10nM (luciferase reporter) |
123 | |
compound 18 | 10nM Reporter displacement 53nM Lanthascreen (CDK8-CCNC) |
IC50 = 65nM (luciferase reporter) |
154 | |
compound 20 | 17.4nM Lanthascreen (CDK8-CCNC) |
IC50 = 6.5nM (luciferase reporter) PDB: 5HVY |
155 | |
compound 25 | 2.6nM Lanthascreen or reporter displacement (CDK8-CCNC) |
IC50 = 6.5nM (luciferase reporter) PDB: 5IDN |
156 | |
compound 32 | 1.5nM assay method unclear |
GI50 = 5.4µM* (HCT116) selective for CDK8 vs. CDK19 |
71 | |
compound 51 | 5.1nM Lanthascreen or reporter displacement (CDK8-CCNC) |
IC50 = 7.2nM (luciferase reporter) |
157 | |
cortistatin A | 12nM in vitro kinase w/ CDK8 module# 100µM ATP |
Kd = 0.2nM (CDK8-CCNC) GI50 = 5nM (MOLM-14) PDB: 4CRL |
48 | |
SEL120-34A | 4.4nM in vitro kinase w/ CDK8-CCNC 10µM ATP |
Kd = 3nM (CDK8-CCNC) GI50 ~ 12nM (SKNO-1) |
158 | |
senexin A | 280nM in vitro kinase w/ CDK8-CCNC |
Kd ~ 800nM (CDK8-CCNC) |
159 | |
sorafenib | 32.5nM Lanthascreen (CDK8-CCNC) |
Kd = 100nM (CDK8-CCNC) PDB: 3RGF |
155 160 |
aThe IC50 results determined from kinase assays will be dependent on ATP concentration, with higher [ATP] yielding higher IC50 values. [ATP] used in the assays is noted if reported.
bOther compounds with similar activity were tested in this study.
*In this study, the GI50 was determined to be due to an off-target effect based upon studies in CDK8 and/or CDK19 knockout cell lines.
#CDK8 module = CDK8, CCNC, MED12, MED13